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Much of our understanding of the generation of antibody diversity stems from 
recombinant DNA studies on myeloma or hybridoma antibodies with unknown 
specificity, or  specificity for  exogenous  antigens  (reviewed  in  1).  Hence,  the 
antibody response to a number of defined haptens in different mouse strains has 
been delineated with respect to the germline elements used and the contribution 
of somatic events to creation of antibody diversity (2-6). Autoantibodies involved 
in autoimmune disease pathogenesis have not been well studied at the molecular 
level, and their genetic origin, inducing agents, and means of circumventing self- 
tolerance remain  largely unknown.  To determine their structural  genetic ele- 
ments (variable [V], 1 diversity [D], joining [J], and constant [C] gene segments), 
we initiated molecular analysis of human and murine hybridoma-derived mono- 
clonal autoantibodies against several self-antigens (7, and unpublished data). Of 
particular  interest  was  whether autoantibodies  use  unique  Ig genes or derive 
from the same germline pool as antibodies to exogenous antigens. 
We report herein the molecular cloning and complete nucleic acid sequence 
of mRNAs corresponding to the heavy (H) and light (L) chains of a  monoclonal 
IgMK anti-DNA autoantibody from the MRL/Mp-lpr/lpr  (MRL/I) strain, which 
spontaneously  develops  a  systemic  lupus  erythematosus  (SLE)-Iike  syndrome 
associated with circulating anti-DNA autoantibodies (8).  Comparisons with pub- 
lished antibody sequences indicate that the H  chain of this autoantibody origi- 
nates from a  V. gene of the 4-hydroxy-3-nitrophenyl (NP) antibody family (2, 
9), and its L chain from a  V  gene of the V~I  group, also found in antibodies to 
exogenous antigens (10,  1 1). The J  segments closely resemble BALB/c J,3 and 
JK4 sequences, respectively, and the deduced C region amino acid sequences are 
identical to those found in non-self-directed IgM~ immunoglobulins. Only the D 
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segment, which is  frequently subject to extensive somatic alterations (1), could 
not be classified. Our findings suggest that, with the possible exception of the D 
segment, this anti-DNA autoantibody and, by extension, perhaps autoantibodies 
in  generaL,  do  not  originate  from autoantibody-specific structural  genetic  ele- 
ments,  but  from  the  same  germline  repertoire  as  antibodies  to  exogenous 
antigens. 
Materials and Methods 
The hybridoma cell line MRL-DNA10 originated from a fusion of 3-mo-old MRL/1 
mouse spleen  cells  with  the  BALB/c nonsecretor myeloma cell line  P3-X63-Ag8.653. 
From  this  fusion,  seven  anti-DNA  autoantibody-secreting hybridoma  lines  (1.4%  of 
growing hybrids) were recovered. The details of their production and characterization 
will be  the  subject  of a  separate  report.  MRL-DNA10  secretes  a  monoclonal  IgM, 
autoantibody with specificity for single-stranded DNA. Autoantibodies of this specificity 
occur in the sera of MRL/I mice at high titers (8). 
Total  cellular  RNA  was  prepared  from  MRL-DNA10  cells  by  the  isothiocyanate 
technique (12).  Poly(A)  ÷ RNA was purified by affinity chromatography over oligo(dT) 
columns (13) and copied into cDNA using the Okayama-Berg cloning procedure (14). 
Escherichia  coli  (strain  MCI061)  were transformed with  the  resulting plasmids  by the 
CaCI~ technique (15), cloned on ampicillin-containing agarose, and transferred to nitro- 
cellulose filters. Replica filters were screened for clones containing H or L chain cDNA 
by hybridization to 32P-labeled C region probes for murine p (ChSpp7) (16) and x (pCRI- 
~40) (17) chain sequences, respectively, using standard procedures (18).  Plasmid DNA 
from positive colonies was prepared by alkaline lysis (19) and digested with a series of 
restriction enzymes, and restriction enzyme maps for H and L chain cDNA species were 
established (Fig.  1). Appropriate fragments were labeled with [~2P]deoxynucleotide tri- 
phosphates on their 3' end with Klenow fragment of DNA polymerase or their 5' end 
with polynucleotide kinase, in each case cut with an appropriate second restriction enzyme, 
and purified on polyacrylamide gels. The eluted fragments were then sequenced by partial 
chemical degradation (20). 
Automated N-terminal amino acid sequence analysis  was performed on an  updated 
model 890M sequencer (Beckman Instruments,  Inc., Fullerton, CA) and phenylthiohy- 
dantoin amino acids were identified by high pressure liquid chromatography (21).  The 
N-terminal L chain sequence was obtained from the unseparated IgM molecule since the 
amino terminus of the H  chains was blocked. For H  chain sequencing, affinity-purified 
M RL-DNA 10 protein was reduced with dithiotreitol, alkylated with iodoacetic acid (22), 
and H and L chains separated by high pressure liquid chromatography. The isolated H 
chains were deblocked with pyroglutamate aminopeptidase (23) and subjected to auto- 
mated  sequence  analysis.  The  nucleic  acid  and  deduced  amino  acid  sequences  were 
compared with immunoglobulin sequences from the National Biomedical Research Foun- 
dation database with the computer program ALIGN (24). 
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FIGURE  1.  Partial restriction enzyme maps and sequencing strategy of MRL-DNAI0 H  and 
L chain cDNAs. Only the fi' ends coding for the 5' untranslated region (5' UT), leader peptide 
(LP), V  region, part of the C  region, and a  short Okayama-Berg (OB) vector fragment are 
shown. Arrows and lines below the maps indicate the direction and length of sequence obtained 
from  sites  3'  end-labeled  (&),  5'  end-labeled  (A),  or  labeled  on  either  end  (&).  The  3' 
untranslated and C regions of both chains were similarly sequenced by using strategies based 
on restriction enzyme maps derived from published BALB/c sequences (26, 31). KOFLER  ET  AL.  807 
Results 
Structural  Genetic Elements  Creating  the MRL-DNAIO H  Chain.  ~1%  of the 
4,000 to 5,000 E. coli colonies transformed with MRL-DNA 10 cDNA hybridized 
to the C~ probe. Restriction enzyme analysis of plasmid DNA from 10 u-positive 
clones suggested the presence of a single IgM H  chain mRNA species (data not 
shown). Three clones contained cDNA inserts of ~2.3  kilobases, which corre- 
sponds to a  full-length secreted IgM message. The entire insert sequence was 
determined and identified as a  copy of an IgM H  chain mRNA, based on the 
similarity of its 3' portion to a published Cu region DNA sequence (see below). 
The correspondence of the respective message with the MRL-DNA10  IgM  H 
chain protein was further supported by matching of the first 12 amino acids, as 
determined by N-terminal sequencing of the deblocked MRL-DNA 10 H  chain, 
with corresponding residues deduced from the cDNA nucleotide sequence. This 
included a proline in position 7 that is rarely found in H chain sequences (9). 
Computer comparison of the sequence encoding the 5'  untranslated region, 
leader peptide, and amino acids 1-94  showed a  high degree of similarity with 
members of a  VH gene family encoding the predominant antibodies to  NP  in 
C57BL/6 (Igh  b) mice (9) and with members of a corresponding gene family from 
the Igh  a haplotype BALB/c strain  (2).  The most closely related V  genes from 
each of the two Igh haplotypes are depicted in  Fig.  2  in comparison with the 
MRL-DNA10 sequence. Similarity was greatest (389 of 397 basepairs, or 98%) 
with the C57BL/6 germline pseudogene 6, which is nonfunctional due to a single 
basepair deletion in codon 22. Since the MRL/I strain carries the Igh  j haplotype 
in the respective locus, 2 the germline gene encoding MRL-DNA10 could be a 
functional  Igh  i  allele  of the  C57BL/6  pseudogene  6.  In  fact,  this  anti-DNA 
autoantibody crossreacted with  NP and dinitrophenyl in a  radioimmunoassay, 
but did not bind nitroiodophenyi (Morrow and Kofler, unpublished observation), 
distinguishing it from the heteroclytic NP antibodies of Igh  b haplotype (25). 
The JH  segment  used  by  the  MRL-DNA10  H  chain  corresponded  to  the 
BALB/c JH3 sequence, with the exception of the first nucleotide (GGG instead 
of TGG  in  codon  99;  Fig.  2).  The close similarity to  BALB/c  (Igh  a) was not 
unexpected, since a BALB/c-identical JH3 segment occurred in an antiphospho- 
choline (anti-PC) antibody protein sequence from the Igh  j strain CBA/J (3). This 
nucleotide difference produced an amino acid substitution  (glycine for trypto- 
phan), and may have resulted from somatic events that occur frequently at this 
position (1).  The relatively short putative D segment (codons 95-97;  codon 98 
was absent) did not show distinct similarity to D segments available for compar- 
ison. 
The  entire  C,  coding  region  (data  not  shown)  differed  from  a  genomic 
BALB/c IgM sequence described by Goldberg et al. (26) in only four nucleotides 
(codons  122-TTC,  143-CTA,  426-AGC,  and  525-TTG  were,  instead,  TTT, 
CTG,  AGT,  and  CTG  in  the  MRL-DNA10  sequence).  All  differences were 
silent,  i.e.,  they did  not  lead  to  an  amino acid  change.  Another  nucleotide 
difference was found in the 3' untranslated region (at position 1991, T  [Ref. 26] 
Kofler, R., R. M. Perlmutter, D. J. Noonan, F.J. Dixon, and A. N. Theofilopoulos.  Restriction 
enzyme analysis of the  Igh  variable  region of the  major  murine lupus  strains.  Manuscript  in 
preparation. C
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became  C).  Our  findings suggest  that  the  Igh-6  locus  (IgM)  of haplotypes a 
(BALB/c) and j  (MRL/I)  is highly conserved, which agrees with the apparent 
inability to serologically distinguish the corresponding proteins of the two hap- 
Iotypes (27). Alternatively, although less likely, the MRL/I Igh-6 locus could be 
allotype a, requiring a  recombinatorial event between an Igh  a C region and an 
Igb  i V  region  sublocus.  The  MRL/I  strain  has  indeed been  considered  Igh  a, 
based on earlier serological typing of the Igh-1  (IgG2a) locus (8).  However, at 
that time the Igb  i haplotype was unknown, and IghJ mice, including the prototype 
strain  CBA]J,  were classified as Igh  a (28).  Furthermore, analysis of restriction 
fragment polymorphism using DNA probes corresponding to the u and a  switch 
region indicated that the MRL/I C region locus is j, not a. ~ 
Structural  Genetic  Elements  Creating the MRL-DNAIO L  Chain.  1-2%  of the 
transformants in the MRL-DNA 10 cDNA library hybridized to the L~ C region 
probe. Restriction enzyme analysis of 10 clones suggested the presence of cDNA 
copies to a  single L~ mRNA species. The nucleic acid sequence (Fig.  3) corre- 
sponded to an apparently functional L~ mRNA species that is assumed to encode 
the  MRL-DNA10  L  chain  protein.  This assumption was substantiated  by the 
complete match  of  18  N-terminal  amino acids  with  those  deduced from  the 
nucleic acid sequence. 
The V~ gene segment-encoded portion (5' untranslated region, leader peptide, 
amino acids  1-95)  showed  96%  similarity  to a  V~I  L  chain  cDNA  sequence 
corresponding to a  hybridoma-derived anti-(Glu6°Ala~°Tyrl°)n (GAT) antibody 
from a  BALB/c mouse (10) (Fig. 3). Comparisons at the protein level revealed 
complete identity with the TEPC-105  L chain sequence up to position 95 (not 
shown). Therefore,  homologous V,  genes,  or  at  least  V~ genes from a  single 
family (V~I), encoded the L chain of the MRL-DNA10 anti-DNA autoantibody, 
the TEPC-105  immunoglobulin, and antibodies with specificity for exogenous 
antigens (e.g., GAT and digoxin) (10,  11). Expression of the TEPC-105 L chain 
protein is controlled by the Igk-Ef2 locus, which is linked to the Igk-Efl and Ly- 
3  locus  on  chromosome  6.  Mouse  strains  of  the  Igk-Ef2  ~  type  (prototype 
BALB/c) express this L chain, whereas Igk-Ef2 b strains (prototype NZB) do not 
(30), suggesting that MRL/I mice are Igk-Ef2L 
The MRL-DNA10 J, segment differed from the BALB/c derived JK4 sequence 
by two nucleotides. The difference in codon  103  (AAA instead of AAG) was 
silent, whereas that in codon  100 (ACG instead of TCG) led to an amino acid 
substitution, i.e., threonine instead of serine (Fig.  3).  These differences could 
result from somatic mutations or, less likely, reflect polymorphism at this locus. 
The C  region and the complete 3'  untranslated region (data not shown) were 
identical  to  a  published  genomic  BALB/c  sequence  (31)  except  for  a  single 
nucleotide difference in codon 205, i.e., ATC instead of ATT, a  silent change. 
This observation further supports the notion that the CK locus may be essentially 
monomorphic. 
s Gautsch, J.,  P. A. Tsonis, R. Kofler, F. J.  Dixon, and A. N. Theofilopoulos. Immunoglobulin 
sequences of lupus mice: restriction fragment polymorphism in the switch region.  Manuscript in 
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Discussion 
The main goal of this study, which is part of an attempt to delineate the genetic 
origin of the major SLE-associated autoantibodies, was to identify and analyze 
the  structural  genetic  elements  (V,  D, J,  and  C  gene  segments) encoding a 
monoclonal  anti-DNA  autoantibody  (MRL-DNA10)  from  the  lupus-prone 
MRL/1 mouse strain. We report the molecular cloning and complete nucleotide 
sequence of cDNA copies corresponding to its H  and L chain mRNAs. This is, 
to our knowledge, the first autoantibody nucleic acid sequence reported. The 
respective clones, which correspond to functional full-length copies of both H 
and L chain messages, have been synthesized in a eukaryotic expression vector 
system and, therefore, permit future functional studies, including study of the 
effect of site-specific mutagenesis and expression in transgenic mice. 
Comparison of the structural elements generating the MRL-DNA10 autoan- 
tibody with published  immunoglobulins revealed that the  3'  untranslated, C, 
and J  regions of both  H  and  L  chain were nearly identical to  corresponding 
sequences of non-autoantibody IgM, molecules. The putative VH gene segment 
was very similar to VH genes of the NP antibody family, and the L chain most 
likely used a  V  gene of the V~I  group that is also expressed in antibodies to 
exogenous antigens.  Only  the  D  segment could  not  be  classified,  and  could 
therefore represent an autoantibody-specific structural element. However, novel 
D segments have been found in non-autoantibody molecules and may be attrib- 
uted to either high levels of somatic mutation, allotypic differences, or unchar- 
acterized D families in the murine genome (5).  Furthermore, additional mono- 
clonal murine anti-DNA and anti-IgG autoantibodies presently analyzed in our 
laboratory use D segments resembling known D sequences. This MRL/I autoan- 
tibody, therefore, derived from structural  genetic elements closely related to 
those encoding antibodies to foreign antigens in normal mice. 
The extent to which the murine anti-DNA response is restricted by the genetic 
elements described here, and the identity and numbers of other VH and VL genes 
that might be involved in generation of anti-DNA autoantibodies, remains to be 
determined. Idiotype analysis, which may indicate the degree of murine anti- 
DNA autoantibody restriction, has yielded controversial results. Common reac- 
tive idiotypes have been observed on anti-DNA autoantibodies from MRL/1 (32) 
and (NZB ×  W)F1 mice (33), suggesting that a limited number of V genes may 
encode most anti-DNA antibodies. Conversely, Tron et al. (34) observed a large 
amount of idiotypic diversity amongst such antibodies from the (NZB ×  W)F1 
strain. Structural studies to address this question directly are, for the most part, 
lacking.  Amino-terminal sequences of two  (NZB  ×  W)Fl-derived monoclonal 
anti-DNA H  chains suggested that one may originate from a  VH gene of the 
S107 gene family, which is involved in the immune response to PC, whereas the 
other resembles the  H  chain  of a  DNA-binding  NZB  myeloma protein  with 
undetermined V  gene origin (35).  The latter H  chain paired with an  L  chain 
whose amino-terminal sequence resembled that of an anti-PC  antibody of the 
V,8  group.  Hence,  the  VH  and  VL  genes giving rise  to  these and  the  MRL- 
DNA 10 anti-DNA autoantibody were probably derived from different families. 
Nucleic acid sequence analysis of several other MRL/1 and (NZB × W)Fl-derived 812  MOLECULAR  ANALYSIS  OF  AN  ANTI-DNA  AUTOANTIBODY 
monoclonal  anti-DNA  autoantibodies  presently  performed  in  our  laboratory 
further support a multigenic origin of the murine anti-DNA response. 
The  genetic  capacity  to  produce  autoantibodies  against  a  variety  of  self- 
antigens, and hence the presence of the respective structural genes in healthy 
individuals and experimental animals, is strongly suggested by numerous obser- 
vations: autoantibodies occur in the sera of humans (reviewed in 36) and mice 
(37) during viral infections, and can be induced in normal background mice by 
bacterial products (38) or introduction of genes such as the autosomai recessive 
Ipr gene  (39).  Autoantibody-secreting hybridomas have  been  recovered  from 
fusions  using  tonsillar  lymphoid cells  from  a  nonautoimmune donor  (40)  or 
normal mouse splenocytes (41). Furthermore, DNA from lupus and normal mice 
of the same Igh haplotypes resulted  2 in essentially identical restriction enzyme 
patterns with labeled  DNA  probes corresponding to various V. gene families, 
suggesting shared Ig V. loci. 
The  above  experiments  leave  little  doubt  about  the  presence  in  normal 
individuals  of  the  structural  genes  to  express  autoantibodies.  They  do  not, 
however, clarify whether autoantibodies derive from a specific subset of V~ and/ 
or V~. germline genes or use the same structural genetic elements as antibodies 
to  exogenous antigens.  This  question  has  relevance  for  possible  mechanisms 
controlling autoantibody expression. In our study, we report that a monoclonal 
IgMK anti-DNA  autoantibody from a  murine model of systemic autoimmunity 
derives from structural genetic elements highly related and possibly identical to 
those  coding for  antibodies  to  foreign  antigens.  If this  observation,  which is 
further supported by the presence ofautoantibody idiotypes on non-autoantibody 
molecules (42), can be generalized, anti-self specificity could result from certain 
combinations of individual elements or entire chains and/or somatic mutations 
of antibodies originally raised against exogenous antigens. The crossreaction of 
a  monoclonal anti-DNA antibody with NP (this report),  the N-terminal amino 
acid sequence similarity between human monoclonal lupus autoantibodies and 
anti-KlebsieUa antibodies (43), and the induction of anti-DNA autoantibodies by 
immunization with cardiolipin  (44)  favor this concept.  Further  direct support 
comes from a recent report (45) on the generation in vitro of an antibody with 
DNA specificity by somatic point mutation in the H chain gene of the PC-binding 
myeloma S 107. Molecular analysis of additional monoclonal anti-DNA and anti- 
IgG autoantibodies, currently in progress in our laboratory,  will hopefully lead 
to more definitive conclusions regarding the genetic origin of lupus-associated 
autoantibodies. 
Summary 
The mRNAs encoding heavy and light chains of a  hybridoma-derived mono- 
clonal  IgM,  anti-DNA  autoantibody  from  lupus-prone  MRL/Mp-lpr/lpr  mice 
(Igh  i) have been transcribed into cDNA copies and molecularly cloned, and their 
complete nucleotide sequences have been determined. The mRNA for the heavy 
chain  variable  region,  including leader  peptide and  5'  untranslated  region,  is 
transcribed  from a  heavy chain variable  region (VH) gene closely related  (and 
possibly allelic) to V. genes of the C57BL/6 (Igh  b) nitrophenyl antibody family. 
The deduced amino acid  sequence corresponding to  the  light  chain  variable KOFLER ET  AL.  813 
region of this autoantibody shows extensive similarities  with non-autoantibody 
molecules  of the  V,I  group,  suggesting  a  common  variable  gene origin.  The 
joining segments, constant regions, and 3' untranslated regions of both the heavy 
and light chain mRNAs are nearly identical to corresponding sequences of non- 
autoantibodies  from  normal  mice.  Our  findings  suggest  that  this  anti-DNA 
autoantibody  originated  from  the  same  germline  repertoire  as  antibodies  to 
exogenous antigens. 
We thank Drs. S.J. Francis, N. R. Klinman, P. R. Morrow, S. C. Riley, P. A. Singer, and 
G. J. Sutcliff for helpful discussions,  Dr. B. F. Tack for providing amino acid sequencing 
facilities, Mr. R. S. Balderas for expert technical assistance, and Ms. M. K. Occhipinti for 
editing and manuscript production. 
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